Transforming Wound Care
MiRAVA Therapeutics is developing 'miRHeal', an advanced wound care therapeutic designed to heal chronic ulcers. Our mission is to create innovative healthcare solutions that improve patient outcomes, enhance quality of life, and reduce healthcare system costs.
miRHeal
Discover our revolutionary approach to treating chronic wounds. miRHeal is a microRNA-based advanced wound healing therapy, rigorously tested across four distinct preclinical models, delivering exceptional results in healing challenging wounds such as diabetic foot ulcers.
MicroRNA Technology
miRHeal is specifically
designed as a microRNA mimic, with the primary goal of promoting vascularisation and expediting the wound healing process.
Non-Invasive Therapy
miRHeal offers a non-invasive approach, where microRNA mimics dissolved in a hydrogel are applied topically to the wound, promoting complete wound closure.
Pre-Clinical Efficacy
Comprehensive pre-clinical studies, including cellular assays, a mouse model, 3D skin models, and diabetic patient skin explants, have demonstrated the efficacy of miRHeal.
Patient-Centric Solutions
miRHeal improves patient quality of life by reducing amputation rates associated with non-healing ulcers, enhancing physical function, and promoting independence.
5
Successful Studies
86
Times Cited
1
Patent Pending
Our Team
Our co-founding team consists of highly qualified and motivated professionals, who are experts in their field.
Dr Vlad Miscianinov
CEO
Vlad Miscianinov, co-founder and CEO of MiRAVA Therapeutics, has a strong research background in molecular biology and gene therapies. He previously successfully managed a healthtech business through fundraising and technology development and now leads MiRAVA Therapeutics in developing and commercialising its innovative wound care product, miRHeal.
Dr Andrea Caporali
CSO
Andrea Caporali, co-founder and CSO of MiRAVA Therapeutics, is also an Associate Professor in Cardiovascular Science at the University of Edinburgh. An expert in vascular biology, his research on microRNA in vascular disease is widely published. Andrea’s expertise directly supports MiRAVA Therapeutics' focus on advanced wound care solutions.
Contact Us
We are actively exploring strategic partnership opportunities. For further details, please contact us at info@miravatherapeutics.com.
Copyright © 2025 MiRAVA Therapeutics | All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.